ACLY Inhibition Boosts Tumor Immunity, Suppresses Liver Cancer
A groundbreaking study has unveiled a novel mechanism by which inhibiting ATP citrate lyase (ACLY) triggers a potent antitumour immune ...
A groundbreaking study has unveiled a novel mechanism by which inhibiting ATP citrate lyase (ACLY) triggers a potent antitumour immune ...
Liver cancer, specifically hepatocellular carcinoma (HCC), represents a formidable challenge in modern oncology, frequently emerging on the backdrop of chronic ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine